Lamzede, illustration of injection vial form (not a photo of the actual pack)

Illustrative image.

Lamzede

Velmanase alfa

Prescription required

$1920.00

10mg · 1 vial

BrandBranded medicine· By Chiesi

Choose a pack

  • Selected pack

Packs in this delivery

1

Test mode: no payment is taken. View cart

Prescription required

Upload your prescription after ordering, or send it to our pharmacy team. We dispense only against a valid prescription.

FDA boxed warningSevere hypersensitivity reactions

Hypersensitivity Reactions Including Anaphylaxis

cardiopulmonary resuscitation equipment

, should be readily available during LAMZEDE administration. If a severe hypersensitivity reaction (e.g., anaphylaxis) occurs,

discontinue

LAMZEDE immediately and

initiate

appropriate medical treatment. In patients with severe hypersensitivity reaction, a desensitization procedure to LAMZEDE may be considered

Appropriate medical support measures, including

, should be readily available. If a severe hypersensitivity reaction occurs,

appropriate medical treatment.

Read this with the rest of the clinical information

About Lamzede

Overview

Lamzede contains velmanase alfa-tycv, a laboratory-made version of the human enzyme alpha-mannosidase. It is used in adults and children to treat the effects of alpha-mannosidosis outside the central nervous system. It works by supplying this enzyme to help break down mannose-containing sugars that build up inside cells when enzyme activity is reduced.

What it treats

Treatment of manifestations of alpha-mannosidosis outside the central nervous system in adults and children.

Safety information

Side effects

Common side effects include allergic reactions, including anaphylaxis, nose and throat inflammation, fever, headache and joint pain. Anaphylaxis is a serious allergic reaction that requires immediate medical attention. Reactions associated with the infusion can also be severe. If a severe infusion reaction occurs, treatment must be stopped and appropriate medical care given. Lamzede may harm an unborn baby. Contact your doctor if you become pregnant during treatment. If you can become pregnant, use effective contraception during treatment and for 14 days after the last dose if treatment is stopped.

FDA boxed warning

Severe hypersensitivity reactions

Hypersensitivity Reactions Including Anaphylaxis

cardiopulmonary resuscitation equipment

, should be readily available during LAMZEDE administration. If a severe hypersensitivity reaction (e.g., anaphylaxis) occurs,

discontinue

LAMZEDE immediately and

initiate

appropriate medical treatment. In patients with severe hypersensitivity reaction, a desensitization procedure to LAMZEDE may be considered

Appropriate medical support measures, including

, should be readily available. If a severe hypersensitivity reaction occurs,

appropriate medical treatment.

A boxed warning is the strongest warning the US Food and Drug Administration requires on a medicine label. Text is taken from the official label, with internal section references removed.

When to call your doctor

- Seek immediate medical attention for a severe allergic reaction, including anaphylaxis. - Seek immediate medical attention for a severe reaction associated with a Lamzede infusion.

If symptoms are severe or getting worse quickly, seek emergency care rather than waiting.

Before taking this medicine

The label lists no contraindications to Lamzede. However, severe infusion-associated reactions require stopping Lamzede and starting appropriate medical treatment. Lamzede may harm an unborn baby. Females who could become pregnant should use effective contraception during treatment and for 14 days after the last dose if treatment is discontinued.

Using Lamzede

Dosing

Dosing is set by your prescriber. Each health care professional may prescribe medication differently according to a patient's medical history and condition, so follow the directions on your prescription label and speak to your doctor or pharmacist before changing anything.

Storage

Store in the original carton below 25°C, protected from light, unless the pack states refrigeration. Do not freeze. Keep all medicines out of the sight and reach of children.

Clinical information on this page is summarised from the US FDA label LAMZEDE (VELMANASE ALFA-TYCV) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [CHIESI USA, INC.] (DailyMed, retrieved 19 September 2026).

Reviews

No reviews yet. Mail Order Drugs opened recently, and we publish reviews only from verified customers of this site, so this space stays empty until real ones arrive.

  • Every prescription order is checked by a licensed pharmacist before dispensing.
  • Payment pages are encrypted and card details never reach our servers.
  • We ship internationally, with cold-chain packing where a medicine needs it.

Related medicines